IDIBELL on the media

IDIBELL launches an experimental cardiology program focusing on research of personalized treatments

This is the first laboratory of its kind in Catalonia IDIBELL launches an experimental cardiology program designed to develop custom clinical applications.  The program specializes in the functional study of platelets and evaluation of the response to antithrombotic and lipid-lowering drugs (decrease blood fat). Response to current drugs Ideal scenario The new laboratory

Erik Sahai:

About Erik Sahai

Lluís Blanch: ‘The key is to go along with the professional who has an innovative idea’

Blanch said that “the key step is to go along with the professional who has an innovative idea” because researchers, doctors or nurses, said Blanch, do not know what steps should taketo negotiate with a company or what is the specific regulation of certain industrial sector. So Corporation Parc Taulí has a recovery and innovation […]

IDIBELL researchers identify new risk indicators of gastric cancer

Most aggressive variant of Helicobacter pylori or the presence of a precancerous lesion in the stomach warn of a high risk of progression to gastric cancer A poor prognosis cancer Create a risk scale Indicators to predict the occurrence of tumor Article’s reference

Roger Gomis: “In metastasis there are more genes that attenuate their expression than overexpressed genes”

About Roger Gomis

The importance of epigenetics in Faculty 1000

Manel Esteller talks about epigenetics in The Scientist magazine

P-REX protein could be a therapeutic target for different types of cancer’

About  Pandiella

IDIBELL Molecular Genetic Diagnosis Centre analyzes more than 1,500 DNA samples per year

There are four thousand rare genetic diseases How does the Center for Molecular Genetic Diagnosis work? Inherited diseases studied at Molecular Genetic Diagnosis Centre

Discovered a substance that acts against the ‘dark genome’ of cancer

The discovery opens the door to new drugs that could revolutionize cancer treatment Enoxacine Article reference

The challenge is to discover new autophagy-inducing drugs to combat neurodegenerative diseases’

About Marta Martínez Vicente

Scroll to Top